Central regions | Finance, business | Technology & innovation
Russia’s stLase medical laser “enthusiastically received” in America and Japan
20 Feb '13
Photonics, a Russian start-up, and its partner have sold “more than ten” innovation stLase laser systems for medical uses since the start of sales in the U.S. and Japan last year. In these countries, sales began in March 2012 and July 2012, respectively, Russian Venture Company (RVC) reports.
Photonics was set up in 2010 in Moscow and has been invested since then by Maxwell Biotech, a Russian VC fund, and RVC’s Seed Fund.
The company has plans to launch sales in South Korea as well. In January 2013, Photonics also began marketing its laser system domestically.
Photonics’ partner for global commercialization is Dental Photonics, a US-based company and co-developer of stLase.
The stLase laser system is a compact laser unit designed for use in a range of treatment methods and procedures on soft tissues. In addition to being compact, its main competitive advantages also include multifunctionality, good ergonomics, and a competitive price. The instrument may be used in dentistry, cardiovascular surgeries, and surgeries in obstetrics, gynecology, otolaryngology, proctology and other areas of medicine.
Alexander Vybornov, the CEO of Dental Photonics, said that “this laser system features best in class medical technology,” adding that “the product’s unprecedented precision, speed, safety and ease of use have been enthusiastically received by top key opinion leaders in the U.S.”